June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Does chronic hypertension modify the effect of chronic ocular hypertension in rats?
Author Affiliations & Notes
  • Bang V Bui
    Optometry and Vision Sciences, The University of Melbourne, Parkville, VIC, Australia
  • Anna K van Koerverden
    Optometry and Vision Sciences, The University of Melbourne, Parkville, VIC, Australia
  • Christine T.O. Nguyen
    Optometry and Vision Sciences, The University of Melbourne, Parkville, VIC, Australia
  • Algis J Vingrys
    Optometry and Vision Sciences, The University of Melbourne, Parkville, VIC, Australia
  • Zheng He
    Optometry and Vision Sciences, The University of Melbourne, Parkville, VIC, Australia
  • Footnotes
    Commercial Relationships Bang Bui, None; Anna van Koerverden, None; Christine Nguyen, None; Algis Vingrys, None; Zheng He, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2439. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bang V Bui, Anna K van Koerverden, Christine T.O. Nguyen, Algis J Vingrys, Zheng He; Does chronic hypertension modify the effect of chronic ocular hypertension in rats?. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2439.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To consider if chronic hypertension protects against chronic intraocular pressure elevation in rats.

Methods: Anesthetised (60:5mg/kg ketamine:xylazine) adult Long-Evans rats were implanted with Alzet osmotic minipumps (2ML4). The hypertensive group (n=8) received subcutaneous infusion of 150ng/kg/min angiotensin II and the normotensive group (n=8) received saline. Four weeks after pump implantation, animals were anesthetised and one randomly selected eye underwent unilateral circumlimbal suture (7/0) to chronically increase IOP. The contralateral eye was left as an untreated control. Systolic blood pressure (SBP) and IOP were measured weekly in awake animals with tail cuff sphygmomanometer and TonoLab, to return ocular perfusion pressure (OPP). Electroretinography and SD-OCT were measured under anesthetisia at baseline, week 4 (before suture application), week 9 and 12. ERG waveforms were analysed to return measures of photoreceptor (a-wave), bipolar cell (b-wave) and RGC (scotopic threshold response, STR) activity. Amplitudes were expressed relative (average%±SEM) to control eyes. OCT images returned retinal ganglion cell complex (GCC), retinal nerve fibre layer (RNFL) and retinal thickness.

Results: SBP was significantly increased in hypertensive rats (160±5mmHg vs 123±2mmHg). Suture application produced IOP elevation in normotensive (over 8 weeks 21.9±0.6 vs 12.9±0.2 mmHg [OPP 102±3 vs 116±2 mmHg]) and hypertensive rats (24.9±1.1 vs 13.3±0.2 mmHg, [OPP 139±4 vs 151±4mmHg]). Systemic hypertension did not alter functional outcomes. IOP elevation produced similar reductions in the a-wave and b-wave in both hypertensive (-5.4±2.0%; -7.0±2.8%) and normotensive rats (-14.7±3.5%; -12.0±2.8%). There was significantly greater attenuation of the STR compared with the a-wave and b-wave (hypertensive -32.1±7.4%; normotensive -27.5±6%). In hypertensive and normotensive rats, by week 12 there was a significant reduction in RNFL thickness (-16.8±2.9%, -18.2±3.6%) with little change in GCC (2.8±1.3%, -1.7±1.6%) or retinal (4.2±1%, 2.1±0.8%) thickness.

Conclusions: Despite the significantly increased OPP secondary to systemic hypertension, retinal function and RNFL thickness were not protected against chronic IOP elevation. This differs from past findings where acute high BP was protective, which indicates that the chronicity of the hypertension may negate the protective effect afforded by improved OPP.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×